noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Union of Concerned Scientists Inc.

COP31 Kicks Off with Dangerous Overshoot of 1.5C of Global Warming[...]
Children's National Medical Center[...]

Nutrition for young athletes - Children's National
Children's National Medical Center[...]

How to pack your kids a healthy and tasty school lunch - Children's[...]

Healthcare

CRISPR Therapeutics AG

11/08/2026 | Press release | Distributed by Public on 11/08/2026 09:38

CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

CRISPR Therapeutics AG published this content on November 08, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 08, 2026 at 15:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]